Literature DB >> 14761207

Macrocyclic polyamines deplete cellular ATP levels and inhibit cell growth in human prostate cancer cells.

Benjamin Frydman1, Subhra Bhattacharya, Aparajita Sarkar, Konstantin Drandarov, Sergiy Chesnov, Armin Guggisberg, Kasim Popaj, Sergey Sergeyev, Aysil Yurdakul, Manfred Hesse, Hirak S Basu, Laurence J Marton.   

Abstract

In solid tumors, when O(2) partial pressure drops below 10 mmHg, ATP levels rapidly decrease due to the Warburg effect. It is known that certain macrocyclic polyamines catalyze the chemical hydrolysis of ATP with release of inorganic phosphate. Since tumor cells have diminished ATP levels as compared to normal cells, we attempted to deplete cellular ATP with macrocyclic polyamines in an effort to inhibit tumor cell proliferation. Five macrocyclic polyamines, related to the budmunchamine family of alkaloids, were prepared by total synthesis. They were the [17]-N(4) macrocycle 1, the [16]-N(4) macrocycle 20, the [18]-N(4) macrocycle 13, the [20]-N(5) macrocycle 8, and the [13]-N(3) macrocycle 17. Each one of them hydrolyzed ATP in vitro with release of P(i); the largest ring macrocycle 8 was the most efficient catalyst, while the smallest ring macrocycle 17 was the least efficient (P(i) released in these runs was on the order of 40-100 microM). The linear polyamine spermine had no hydrolytic effect on ATP. The macrocycles were found to be cytotoxic when assessed by means of a MTT assay against two human prostate cell lines, DuPro and PC-3, with resultant ID(50) values ranging between 0.5 and 1.8 microM. Colony forming efficiency (CFE) assays performed on DuPro cells, where the macrocycles were used in a concentration range of 1-8 microM, confirmed the cytotoxic effect of each macrocycle. Each killed 3-4 log of DuPro cells. The smallest ring 17 was the least cytotoxic after 24 h of incubation, although after 144 h of incubation it showed significant cytotoxicity at 8 microM. The macrocycles were equally efficient in depleting the intracellular ATP pools; after a 24 h incubation with each macrocycle other than 17 at 1-8 microM concentrations, cellular ATP concentrations were decreased by 3 orders of magnitude. The decrease in ATP levels was more pronounced after a 72 h incubation, when even 17 reduced ATP by 2 orders of magnitude. A linear pentamine of established cytotoxicity was without effect on the ATP pools. The macrocycles depleted almost entirely the intracellular pools of polyamines and were efficiently taken up by cells. A rough correlation could be established between the cytotoxic effect of the macrocyclic polyamines and their ATP-ase like activity in the DuPro cell line. As ATP is a scarce metabolite in cancer cells, where it can only be replenished through the very ATP-inefficient glycolytic pathway; macrocyclic polyamines appear to be promising new anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761207     DOI: 10.1021/jm030437s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.

Authors:  Dong Jin Hwang; Jun Yang; Huiping Xu; Igor M Rakov; Michael L Mohler; James T Dalton; Duane D Miller
Journal:  Bioorg Med Chem       Date:  2006-07-07       Impact factor: 3.641

Review 2.  Recent advances in the development of polyamine analogues as antitumor agents.

Authors:  Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

3.  Catalysis-based enantioselective total synthesis of the macrocyclic spermidine alkaloid isooncinotine.

Authors:  Bodo Scheiper; Frank Glorius; Andreas Leitner; Alois Fürstner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

4.  The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib.

Authors:  Jennifer S Carew; Steffan T Nawrocki; Venudhar K Reddy; Dorothy Bush; Jerold E Rehg; Andrew Goodwin; Janet A Houghton; Robert A Casero; Laurence J Marton; John L Cleveland
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

Review 5.  Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family.

Authors:  Natalia Goldin; Alina Heyfets; Dorit Reischer; Eliezer Flescher
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

Review 6.  The Emerging Clinical Role of Spermine in Prostate Cancer.

Authors:  Qiang Peng; Christine Yim-Ping Wong; Isabella Wai-Yin Cheuk; Jeremy Yuen-Chun Teoh; Peter Ka-Fung Chiu; Chi-Fai Ng
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

7.  A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer.

Authors:  Kaixuan Guo; Cong Lai; Juanyi Shi; Zhuang Tang; Cheng Liu; Kuiqing Li; Kewei Xu
Journal:  Front Oncol       Date:  2021-09-14       Impact factor: 6.244

8.  Competition-driven selection in covalent dynamic networks and implementation in organic reactional selectivity.

Authors:  P Kovaříček; A C Meister; K Flídrová; R Cabot; K Kovaříčková; J-M Lehn
Journal:  Chem Sci       Date:  2016-02-10       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.